PBAC and MSAC submission and commercialisation guidance

Optumâ„¢ can assist with the clinical and economic evidence you need to submit your new drug or medical device by providing a greater understanding of the specific application guidelines and timeframes of the Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC).

Please review our newly created PBAC and MSAC submission deadlines and projected effective dates to see the appropriate timeline required for your specific drug or device submission. The provided interactive submissions calendar allows you add important dates to your own Outlook calendar to ensure you stay on track with submissions.

References: